Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-10 6:51 pm Purchase |
2025-01-06 | 13G | BioLineRx Ltd. BLRX |
Mitchell P. Kopin | 2,555,903 4.990% |
2,077,581 (+434.35%) |
Filing History |
| 2025-01-03 8:08 pm Purchase |
2024-12-27 | 13G | 180 Life Sciences Corp. ATNF |
Mitchell P. Kopin | 165,293 4.990% |
165,293 (New Position) |
Filing History |
| 2025-01-03 8:04 pm Purchase |
2024-12-26 | 13G | Gaxos.ai Inc. GXAI |
Mitchell P. Kopin | 363,625 4.990% |
70,728 (+24.15%) |
Filing History |
| 2024-12-30 5:39 pm Purchase |
2024-12-22 | 13G | Vivos Therapeutics, Inc. VVOS |
Mitchell P. Kopin | 297,315 4.990% |
297,315 (New Position) |
Filing History |
| 2024-12-27 5:05 pm Purchase |
2024-12-19 | 13G | Phio Pharmaceuticals Corp. PHIO |
Mitchell P. Kopin | 90,987 4.990% |
45,782 (+101.28%) |
Filing History |
| 2024-12-26 4:23 pm Purchase |
2024-12-18 | 13G | Gaxos.ai Inc. GXAI |
Mitchell P. Kopin | 292,897 4.990% |
292,897 (New Position) |
Filing History |
| 2024-11-13 11:20 am Purchase |
2024-09-30 | 13G | Phio Pharmaceuticals Corp. PHIO |
Mitchell P. Kopin | 45,205 4.990% |
45,205 (New Position) |
Filing History |
| 2024-11-13 11:19 am Purchase |
2024-09-30 | 13G | Nuvve Holding Corp. NVVE |
Mitchell P. Kopin | 34,281 4.990% |
34,281 (New Position) |
Filing History |
| 2024-11-13 11:19 am Sale |
2024-09-30 | 13G | PharmaCyte Biotech, Inc. PMCB |
Mitchell P. Kopin | 793,747 9.990% |
-109,665 (-12.14%) |
Filing History |
| 2024-11-13 11:18 am Purchase |
2024-09-30 | 13G | Innovative Eyewear, Inc. LUCY |
Mitchell P. Kopin | 126,073 4.990% |
126,073 (New Position) |
Filing History |
| 2024-11-13 11:18 am Sale |
2024-09-30 | 13G | PainReform Ltd. PRFX |
Mitchell P. Kopin | 26,202 4.500% |
-24,198 (-48.01%) |
Filing |
| 2024-11-13 11:18 am Unchanged |
2024-09-30 | 13G | NAYA Biosciences, Inc. NAYA |
Mitchell P. Kopin | 15,333 4.500% |
0 (Unchanged) |
Filing History |
| 2024-11-13 11:18 am Purchase |
2024-09-30 | 13G | Enveric Biosciences, Inc. ENVB |
Mitchell P. Kopin | 1,289 3.100% |
644 (+100.00%) |
Filing History |
| 2024-11-13 11:17 am Sale |
2024-09-30 | 13G | Tantech Holdings Ltd TANH |
Mitchell P. Kopin | 10,956 4.990% |
-9,423 (-46.24%) |
Filing History |
| 2024-11-13 11:16 am Purchase |
2024-09-30 | 13G | Tian Ruixiang Holdings Ltd TIRX |
Mitchell P. Kopin | 53,667 2.200% |
0 (+0.00%) |
Filing History |
| 2024-11-13 11:15 am Purchase |
2024-09-30 | 13G | Interactive Strength Inc. TRNR |
Mitchell P. Kopin | 808,179 4.500% |
808,179 (New Position) |
Filing History |
| 2024-11-13 11:15 am Purchase |
2024-09-30 | 13G | Bio-Path Holdings, Inc. BPTH |
Mitchell P. Kopin | 194,862 4.990% |
141,162 (+262.87%) |
Filing History |
| 2024-11-13 11:14 am Purchase |
2024-09-30 | 13G | Catheter Precision, Inc. VTAK |
Mitchell P. Kopin | 181,336 4.990% |
19,331 (+11.93%) |
Filing History |
| 2024-11-13 11:14 am Purchase |
2024-09-30 | 13G | Bone Biologics Corporation BBLG |
Mitchell P. Kopin | 110,122 4.990% |
10,517 (+10.56%) |
Filing History |
| 2024-11-13 11:14 am Purchase |
2024-09-30 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Mitchell P. Kopin | 504,550 4.990% |
349,782 (+226.00%) |
Filing History |